the causes of excess CVD in males remain unclear. 2 Efforts to pinpoint the causes of the disparity have been hampered by a lack of understanding of the basic historical trends in sex differences in CVD. Moriyama et al.5"2 found that sex differences in CVD mortality in the United States were small in 1920 and increased over the period 1920 through 1947. Anderson and Halliday'3"14 reached similar conclusions for heart disease mortality in Canada, the United States, and England and Wales. One study examined data from England and Wales in 5 selected years: 1901, 1931, 1951, 1970, and 1982.4 It showed that male excess mortality from CVD was increasing over time. However, this material was not extensive enough to permit definite conclusions, as only 5 selected years were investigated and there were many revisions of the International Classification ofDiseases (ICD) during this time, making comparisons of these 5 years questionable.
Collectively, results suggest that there were historical changes in the pattem of sex differences in CVD. However, because little effort has been made to summarize historical trends over the full range of available data, there is no clear understanding of whether male excess mortality from CVD has existed throughout history. We therefore conducted a more thorough and careful investigation of trends in mortality differences between males and females from the time when data first became available until the present, including the full range of age groups. This analysis should help clarify the trends of male excess mortality from CVD. We also investigated the relationship between these trends and the trends in male excess mortality from all causes. Thus, we examined mortality data for England and Wales, the region having the oldest available mortality statistics by cause, for the period 1861 through 1992, and the United States for the period 1900 through 1991.
Data and Methods
Mortality statistics for CVD in England and Wales were used for the years 1861, 1871, 1881, 1891, 1901, 1911-1914, 1921, 1922, 1925, 1931, 1934, 1936, 1937, 1940, 1943-1971, and 1973-1992 1861, 1871, 1881, 1891, 1901, 1911, 1921, 1931, 1940, and 1951 . To obtain data in intermediate years, we conducted the same work for the years 1912-1914, 1922, 1925, 1936-1937, and 1943-1950 Figure 2 ). In general, the basic patterns were the same.
For the middle age groups, there was an early stage with no apparent male excess mortality from CVD: male and female mortalities did not differ by more than 22% for the age groups between 25 and 74 years in the period before the 1920s. The second stage (from the 1920s to the 1960s) was characterized by intensively increasing male excess mortality from CVD. The third stage (the 1960s to the present) was characterized by a consistently present male excess mortality from CVD and stabilization of the magnitude of the sex differences.
These stages are depicted in clearer detail in Figure 3 , which represents male:female mortality ratios in the United States from 1900 through 1991 for 11 The period under investigation comprises 9 revisions of the ICD code. It is widely accepted that ICD changes manifest themselves in a discontinuity of trends resulting from the change from one ICD system to another. Figures 1 through 3 show that male excess mortality appeared as a steady year-by-year trend within several adjacent revisions, not as major shifts at the time points corresponding to the ICD changes. Therefore, the rise in male excess mortality does not seem to be the result of changes in ICD classifications.
The appearance of male excess mortality from CVD was closely correlated with the appearance of male excess mortality from all causes, as shown in Figure 3 . In fact, the correlation is nearly perfect for ages older than 45. This observation limits the possibility that this phenomenon is a spurious trend resulting from changes in classification or diagnostic practices. It also suggests that historical trends in the male-tofemale mortality ratio for deaths from all causes are largely due to changes in male and female CVD mortality patterns.
We conclude that the appearance of a sex disparity in CVD mortality is most probably a real phenomenon. This contradicts the view that males are inherently more vulnerable to CVD than females. Rather, it suggests that factors disproportionately affecting males and females began entering industrialized societies in the 1920s, giving rise to male excess mortality. Male-female differences in death rates were slightly increased for hypertensive heart disease and cerebrovascular disease. The category "all other forms of heart disease" is also characterized by male excess mortality. The above-cited increasing trends in sex differences in the main CVD components make it unlikely that the trends in sex differences in CVD are due to changes in the relative importance of causes of death with large vs small sex differentials. Instead, the reason for male excess mortality from CVD may best be understood by considering the etiology of IHD. In addition, historical trends in male and female CVD mortality are best examined from an analysis of the entire category of CVD, because (1) the accuracy of mortality data for the entire category is one or two orders of magnitude higher than that for specific components; (2) the subdivision of CVD into different components may be artificial and arbitrary, while the CVD category is naturally distinctive from other categories in most cases; and (3) different CVD components are related, for example, IHD is influenced by hypertension.
To date, there have been many hypotheses to explain male excess mortality from CVD. Here we review these hypotheses in relation to the patterns observed in the present study. Inasmuch as male excess mortality from CVD appeared only in certain periods, these hypotheses do not seem to explain this effect (although they may explain some of the intermediate mechanisms). A second class of hypotheses proposes a protective effect of the female lifestyle. These include the hypothesis of a more favorable female diet5,25 and more female attention to personal health.25 28 These hypotheses are not consistent with the mortality trends in the period of rising male excess mortality. As Figures 1 and 2 show, the sex differences in CVD mortality occurred because of unfavorable tendencies in male mortality and not because of favorable tendencies in female mortality, as would be the case if differences in mortality were due to improvements in female lifestyles. Others One prospective study of more than 1 million men and women (representing almost all segments of the US population)36 contains age-and sex-specific death rates for HID (the main subdivision of CVD and the chief CVD subdivision responsible for sex differences in CVD mortality4) for smokers and nonsmokers. If the cigarette smoking hypothesis is true, then the sex ratio for CVD deaths among nonsmokers should be around 1. The sex ratios for mortality from IHID for nonsmokers aged 45-54, 55-64, 65-74, and 75-84 years are 4.55, 3.33, 2.14, and 1.59, respectively. The ratios for cigarette smokers are 6.39, 3.62, 2.15, and 1.64. Nonsmoking males also have a much higher mortality rate than nonsmoking females. So, in spite of the fact that cigarette smoking is a wellestablished risk factor for CVD and apparently contributes to the sex disparity in CVD, it is unlikely to be the principal cause of the sex differences found. A similar conclusion was suggested on the basis of opposite trends in sex ratios in HIED mortality and sex ratios in cigarette smoking during the 1950s and 1960s.25 At the same time, changes in sex ratios in cigarette smoking are expected to influence male excess mortality from CVD. Recent small-scale declines in male excess mortality from CVD are likely to be the result of a decline in sex differences in cigarette smoking.
At present, many consider a multivariate explanation to be the most plausible. 2'8'37 Wingard8 examined the sex mortality differential (in total mortality) in relation to 10 demographic and behavioral factors. Johnson37 attempted to explain the sex differential in IHD by controlling for 6 of the most important known clinical risk factors: serum cholesterol, systolic blood pressure, diastolic blood pressure, left-ventricular hypertrophy, cigarette smoking, and glucose intolerance. Both studies concluded that the sex differences in IHD cannot be explained by the joint effect of the factors studied. Thus, neither the traditional single-factor hypotheses nor the multivariate approach seem to adequately explain male excess mortality from CVD. It is likely that the main cause of this phenomenon is not presently known. We believe that the analysis of secular trends in sex differences in CVD in different countries is a useful tool to help identify this cause (or causes). Hypotheses should be screened for their concordance with the regularities of male and female secular trends in CVD. A key strategy is to identify factors possibly responsible for the male-female disparity in CVD, which began affecting industrialized societies in the 1920s and stabilized bythel960s. D
